Trifluoromethyldeschloroketamine

Trifluoromethyldeschloroketamine
Clinical data
ATC code	none;
Legal status
Legal status	CA: Schedule I ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ;
Identifiers
	IUPAC name 2-(methylamino)-2-[2-(trifluoromethyl)phenyl]cyclohexan-1-one;
CAS Number	1782149-73-8 ;
PubChem CID	117067835;
UNII	GW3LZ66WZ6;
Chemical and physical data
Formula	C14H16F3NO
Molar mass	271.283 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CNC1(CCCCC1=O)C2=CC=CC=C2C(F)(F)F;
	InChI InChI=1S/C14H16F3NO/c1-18-13(9-5-4-8-12(13)19)10-6-2-3-7-11(10)14(15,16)17/h2-3,6-7,18H,4-5,8-9H2,1H3; Key:LETHPPJNGNSLDJ-UHFFFAOYSA-N;

Trifluoromethyldeschloroketamine (TFMDCK) is a designer drug from the arylcyclohexylamine family, which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. It has been sold over the internet since around 2016, though genuine samples appear to be rare.[1] The o-trifluoromethyl analogue of hydroxynorketamine has also been researched as an antidepressant.[2]

References

Wallach J, Brandt SD (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". Handbook of Experimental Pharmacology. 252: 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. PMID 30196446.
种长效化合物的制备方法. Chinese patent CN 110540510A, 18 June 2019

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.